BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37086484)

  • 1. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.
    Liu M; Li N; Tang H; Chen L; Liu X; Wang Y; Lin Y; Luo Y; Wei S; Wen W; Chen M; Wang J; Zhang N; Chen J
    Oncologist; 2023 Sep; 28(9):e723-e736. PubMed ID: 37086484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
    Ooki A; Osumi H; Fukuda K; Yamaguchi K
    Cancer Metastasis Rev; 2023 Sep; 42(3):1021-1054. PubMed ID: 37422534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review.
    Regalla DKR; Deep O; Paluri RK
    Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.
    Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y
    J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.
    Jeong SY; Park YS; Lee J; Jang J; Jeon Y; Jung YJ; Choi D; Hong J; Kim ST
    J Gastrointest Oncol; 2023 Aug; 14(4):1707-1714. PubMed ID: 37720428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.
    Yang L; Lin H; Shen Y; Roy M; Albarracin C; Ding Q; Huo L; Chen H; Wei B; Bu H; Bedrosian I; Wu Y
    Breast Cancer Res Treat; 2023 Nov; 202(1):23-32. PubMed ID: 37566192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
    Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
    Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.
    Dayton TL; Alcala N; Moonen L; den Hartigh L; Geurts V; Mangiante L; Lap L; Dost AFM; Beumer J; Levy S; van Leeuwaarde RS; Hackeng WM; Samsom K; Voegele C; Sexton-Oates A; Begthel H; Korving J; Hillen L; Brosens LAA; Lantuejoul S; Jaksani S; Kok NFM; Hartemink KJ; Klomp HM; Borel Rinkes IHM; Dingemans AM; Valk GD; Vriens MR; Buikhuisen W; van den Berg J; Tesselaar M; Derks J; Speel EJ; Foll M; Fernández-Cuesta L; Clevers H
    Cancer Cell; 2023 Dec; 41(12):2083-2099.e9. PubMed ID: 38086335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on lung neuroendocrine neoplasm classification.
    Vocino Trucco G; Righi L; Volante M; Papotti M
    Histopathology; 2024 Jan; 84(1):67-85. PubMed ID: 37794655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms.
    Angerilli V; Sabella G; Simbolo M; Lagano V; Centonze G; Gentili M; Mangogna A; Coppa J; Munari G; Businello G; Borga C; Schiavi F; Pusceddu S; Leporati R; Oldani S; Fassan M; Milione M
    Br J Cancer; 2024 May; ():. PubMed ID: 38729995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.
    Sultana Q; Kar J; Verma A; Sanghvi S; Kaka N; Patel N; Sethi Y; Chopra H; Kamal MA; Greig NH
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Present and future of immunotherapy in Neuroendocrine Tumors".
    Albertelli M; Dotto A; Nista F; Veresani A; Patti L; Gay S; Sciallero S; Boschetti M; Ferone D
    Rev Endocr Metab Disord; 2021 Sep; 22(3):615-636. PubMed ID: 33851319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms].
    Wu JH; Zhu YL; Wang HY; Liu YH; Lin DM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):109-115. PubMed ID: 38281776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.
    Oronsky B; Ma PC; Morgensztern D; Carter CA
    Neoplasia; 2017 Dec; 19(12):991-1002. PubMed ID: 29091800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms.
    Boemi I; Piccini S; Colombo FS; Smiroldo V; Zerbi A; Capretti G; Alloisio M; Trivellin G; Lavezzi E; Mazziotti G; Vitali E; Lania AG
    Endocrine; 2024 Mar; 83(3):810-823. PubMed ID: 37845576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
    Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
    Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.
    Giraldo NA; Drill E; Satravada BA; Dika IE; Brannon AR; Dermawan J; Mohanty A; Ozcan K; Chakravarty D; Benayed R; Vakiani E; Abou-Alfa GK; Kundra R; Schultz N; Li BT; Berger MF; Harding JJ; Ladanyi M; O'Reilly EM; Jarnagin W; Vanderbilt C; Basturk O; Arcila ME
    Clin Cancer Res; 2022 Dec; 28(24):5359-5367. PubMed ID: 36228155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
    Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
    Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Biology of Midgut Neuroendocrine Neoplasms.
    Webster AP; Thirlwell C
    Endocr Rev; 2024 May; 45(3):343-350. PubMed ID: 38123518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.